Clinical Features and Treatment Outcomes of 79 Infants with Immune Thrombocytopenic Purpura

Pediatric Blood and Cancer

Volumn 42, Issue 1, 2004, Pages 109-112

  Sandoval, Claudio ^a   Visintainer, Paul ^a   Ozkaynak, M Fevzi ^a   Tugal, Oya ^a   Jayabose, Somasundaram ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Clinical features; Infancy; Thrombocytopenia

Indexed keywords

IMMUNOGLOBULIN D ANTIBODY; MEASLES MUMPS RUBELLA VACCINE; PREDNISONE; STEROID;

ARTICLE; BLEEDING; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL PROTOCOL; FEMALE; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOSAL BLEEDING; NEUROLOGIC DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; PURPURA; RETROSPECTIVE STUDY; SCORING SYSTEM; STATISTICAL ANALYSIS; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0842291479     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.10458     Document Type: Article

References (18)

1. Nugent DJ. Childhood immune thrombocytopenic purpura. Blood Rev 2002;16:27-29.
2. Jayabose S, Sandoval C, Levendoglu-Tugal O, et. al. Long-term outcome of chronic immune thrombocytopenic purpura in children. J Pediatr Hematol Oncol 2003;25:A21.
3. Clayton D, Hills M. Statistical methods in epidemiology. Oxford: Oxford University Press; 1993.
4. Kühne T, Imbach P, Bolton-Maggs PH, et al. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: An observational study. Lancet 2001;358:2122-2125.
5. Medeiros D, Buchanan GR. Major hemorrhage in children with idiopathic thrombocytopenic purpura: Immediate response to therapy and long-term outcome. J Pediatr 1998;133:313-314.
6. Dickerhoff R, von Ruecker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J Pediatr 2000;137:629-632.
7. Ballin A, Kenet G, Tamary H, et al. Infantile idiopathic thrombocytopenic purpura. Pediatr Hematol Oncol 1990;7:323-328.
8. Hord JD, Whitlock JA, Grossman NJ. Immune thrombocytopenic purpura in infants. Arch Pediatr Adolesc Med 1994;148:333-334.
9. Lowe EJ, Buchanan GR. Idiopathic thrombocytopenic purpura diagnosed during the second decade of life. J Pediatr 2002;141:253-258.
10. Aronis S, Platokouki H, Mitsika A, et al. Seventeen years of experience with chronic idiopathic thrombocytopenic purpura in childhood. Is therapy always better? Pediatr Hematol Oncol 1994;11:487-498.
11. Reid MM. Chronic idiopathic thrombocytopenic purpura: Incidence, treatment, and outcome. Arch Dis Child 1995;72:125-128.
12. Imbach P, Akatsuka J, Blanchette V, et al. Immunothrombocytopenic purpura as a model for pathogenesis and treatment of autoimmunity. Eur J Pediatr 1995;154(Suppl 4):S60-S64.
13. Miller E, Waight P, Farrington CP, et al. Idiopathic thrombocytopenic purpura and MMR vaccine. Arch Dis Child 2001;84:227-229.
14. Vlacha V, Forman EN, Miron D, et al. Recurrent thrombocytopenic purpura after repeated measles-mumps-rubella vaccination. Pediatrics 1996;97:738-739.
15. Drachtman RA, Murphy S, Ettinger LJ. Exacerbation of chronic idiopathic thrombocytopenic purpura following measles-mumps-rubella immunization. Arch Pediatr Adolesc Med 1994;148:326-327.
16. Watson JC, Hadler SC, Dykewicz CA, et al. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella and congenital rubella syndrome and control of mumps: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1998;47(RR-8):1-57.
17. Lee SY, Komp DM, Andiman W. Thrombocytopenic purpura following varicella-zoster vaccination. Am J Pediatr Hematol Oncol 1986;8:78-80.
18. Ronchi F, Cecchi P, Falcioni F, et al. Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine. Arch Dis Child 1998;78:273-274.